Azacitidine in combination with venetoclax, gilteritinib, midostaurin or other compounds for treating leukemia or myelodysplastic syndrome
US-12447171-B2 · Oct 21, 2025 · US
Dai Yumin is listed as an inventor on 7 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Dai Yumin |
| Total patents | 7 |
| First publication | Oct 15, 2020 |
| Latest publication | Oct 21, 2025 |
Publications ranked by popularity score, then publication date.
US-12447171-B2 · Oct 21, 2025 · US
US-11896591-B2 · Feb 13, 2024 · US
US-11708376-B2 · Jul 25, 2023 · US
US-2022249528-A1 · Aug 11, 2022 · US
US-2022249529-A1 · Aug 11, 2022 · US
US-2021238181-A1 · Aug 5, 2021 · US
US-2020323846-A1 · Oct 15, 2020 · US
Latest publications not already listed above.
No data yet.
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Virginia Tech Intellectual Properties Inc | 4 |
| Univ Virginia Patent Foundation | 2 |
| Newsouth Innovations Pty Ltd | 2 |
| Celgene Quanticel Res Inc | 2 |
| Univ Of Virgina Patent Foundation | 1 |
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61K45/06 | 5 |
| A61K31/4965 | 4 |
| C07D487/04 | 4 |
| A61P3/04 | 4 |
| A61P3/08 | 4 |